Adial Pharmaceuticals, Inc. (ADIL)
6.36
-0.29
(-4.36%)
USD |
NASDAQ |
Sep 09, 09:58
Adial Pharmaceuticals Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 29, 2026 | 1.052 |
| June 26, 2026 | 1.039 |
| June 25, 2026 | 1.048 |
| June 24, 2026 | 1.007 |
| June 23, 2026 | 1.035 |
| June 22, 2026 | 1.100 |
| June 18, 2026 | 1.056 |
| June 17, 2026 | 1.116 |
| June 16, 2026 | 1.031 |
| June 15, 2026 | 1.157 |
| June 12, 2026 | 1.210 |
| June 11, 2026 | 1.210 |
| June 10, 2026 | 0.8769 |
| June 09, 2026 | 0.8648 |
| June 08, 2026 | 0.8972 |
| June 05, 2026 | 0.8972 |
| June 04, 2026 | 0.9825 |
| June 03, 2026 | 0.9419 |
| June 02, 2026 | 0.9581 |
| June 01, 2026 | 0.9947 |
| May 29, 2026 | 0.9744 |
| May 28, 2026 | 1.027 |
| May 27, 2026 | 0.9703 |
| May 26, 2026 | 0.9094 |
| May 22, 2026 | 0.8445 |
| Date | Value |
|---|---|
| May 21, 2026 | 0.9338 |
| May 20, 2026 | 0.9541 |
| May 19, 2026 | 0.8363 |
| May 18, 2026 | 0.6536 |
| May 15, 2026 | 0.5603 |
| May 14, 2026 | 0.5522 |
| May 13, 2026 | 0.5603 |
| May 12, 2026 | 0.5603 |
| May 11, 2026 | 0.5846 |
| May 08, 2026 | 0.5806 |
| May 07, 2026 | 0.5765 |
| May 06, 2026 | 0.6415 |
| May 05, 2026 | 0.6496 |
| May 04, 2026 | 0.6496 |
| May 01, 2026 | 0.6293 |
| April 30, 2026 | 0.6252 |
| April 29, 2026 | 0.6293 |
| April 28, 2026 | 0.6334 |
| April 27, 2026 | 0.6334 |
| April 24, 2026 | 0.6415 |
| April 23, 2026 | 0.6334 |
| April 22, 2026 | 0.6374 |
| April 21, 2026 | 0.6455 |
| April 20, 2026 | 0.6618 |
| April 17, 2026 | 0.6618 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 31.57 |
| ANI Pharmaceuticals, Inc. | 2.699 |
| Corcept Therapeutics, Inc. | 17.79 |
| Veru, Inc. | 1.538 |
| Johnson & Johnson | 7.639 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0159 |
| Price | 6.36 |
| Earnings Yield | -260.1% |
| Market Cap | 16.70M |
| PEGY Ratio | -0.0159 |